|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.868
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
0.683
|
|
|
|
chromatin disassembly
|
GO:0031498 |
1 |
0.630
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.506
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.409
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.387
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.375
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.344
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.304
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.293
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.289
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.282
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.256
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.249
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.246
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.235
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.231
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.222
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.222
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.219
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.218
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.201
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.198
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.195
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.183
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.176
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.175
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.167
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.166
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.164
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.158
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.157
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.154
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.151
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.151
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.150
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.148
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.142
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.139
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.139
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.128
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.128
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.124
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.119
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.118
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.118
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.114
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.113
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.110
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.108
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.108
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.106
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.105
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.105
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.104
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.104
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.104
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.102
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.101
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.100
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.099
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.098
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.097
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.095
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.094
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.093
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.090
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.089
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.088
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.088
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.087
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.087
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.086
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.086
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.085
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.085
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.084
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.083
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.082
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.082
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.081
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.081
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.078
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.077
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.077
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.077
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.077
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.077
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.076
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.076
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.075
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.075
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.075
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.075
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.074
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.073
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.072
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.072
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.072
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.072
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.072
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.072
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.070
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.069
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.069
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.068
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.067
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.067
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.066
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.066
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.065
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.065
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.065
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.065
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.064
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.063
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.063
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.063
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.062
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.061
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.061
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.061
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.061
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.061
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.060
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.060
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.058
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.058
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.058
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.057
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.057
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.057
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.057
|
|
|
|
memory
|
GO:0007613 |
58 |
0.056
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.056
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.055
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.055
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.055
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.055
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.054
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.054
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.054
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.054
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.053
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.052
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.052
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.052
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.050
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.050
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.050
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.050
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.049
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.049
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.048
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.048
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.047
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.047
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.047
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.047
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.047
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.047
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.046
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.046
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.046
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.045
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.045
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.045
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.045
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.044
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.044
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.043
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.043
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.043
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.043
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.042
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.042
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.042
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.041
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.041
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.041
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.040
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.040
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.040
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.040
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.040
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.039
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.039
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.039
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.039
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.039
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.038
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.038
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.038
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.038
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.037
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.037
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.037
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.037
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.037
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.037
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.037
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.037
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.036
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.036
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.036
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.036
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.036
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.036
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.036
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.035
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.035
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.034
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.034
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.034
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.033
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.033
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.032
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.032
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.031
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.031
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.031
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.031
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.031
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.031
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.031
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.031
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.030
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.030
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.030
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.030
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.030
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.030
|
|
|
|
biofilm formation
|
GO:0042710 |
1 |
0.029
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.029
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.029
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.029
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.029
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.029
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.028
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.028
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.027
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.027
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.027
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.027
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.027
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.027
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.027
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.026
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.026
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.026
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.026
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.026
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.026
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.026
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.026
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.026
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.026
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.025
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.025
|
|
|
|
regulation of antibacterial peptide production
|
GO:0002786 |
1 |
0.025
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.024
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.024
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.024
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.024
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.024
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.024
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.024
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.024
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.024
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.023
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.023
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.023
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.023
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.022
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.022
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
18 |
0.022
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.022
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.022
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.022
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.022
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.022
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.022
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.022
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.022
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.022
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.022
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.021
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.021
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.021
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.021
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.021
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.021
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.021
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.021
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
single species biofilm formation
|
GO:0044010 |
1 |
0.021
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.020
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.020
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.020
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.020
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.020
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.020
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.020
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.020
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.020
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.020
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.019
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.019
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.019
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.019
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.019
|
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
12 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.019
|
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
7 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.019
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.019
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.019
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.019
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.019
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.019
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.019
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.019
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.019
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.019
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.019
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.019
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.019
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.018
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.018
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.018
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.018
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.018
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.018
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.018
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.018
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.018
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.018
|
|
|
|
dna methylation on cytosine
|
GO:0032776 |
5 |
0.018
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.018
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.017
|
|
|
|
cellular response to salt stress
|
GO:0071472 |
1 |
0.017
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.017
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.016
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.016
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.016
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.016
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.016
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.016
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.016
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.016
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.016
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.015
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.015
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.015
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.015
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.015
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.015
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.015
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.015
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.015
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.015
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.015
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.015
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.015
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.015
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.015
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.014
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.014
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.014
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.014
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.014
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.014
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.014
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.014
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.014
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.014
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.014
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.014
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.014
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.014
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.014
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
blastocyst hatching
|
GO:0001835 |
4 |
0.014
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.013
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.013
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.013
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.013
|
|
|
|
cellular protein complex disassembly
|
GO:0043624 |
36 |
0.013
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.013
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.013
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.013
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.013
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.013
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.013
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.013
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.013
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.013
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.013
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.013
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.013
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.013
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.013
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
regulation of inositol trisphosphate biosynthetic process
|
GO:0032960 |
3 |
0.013
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.013
|
|
